Behnam Badie

12.2k total citations · 1 hit paper
137 papers, 7.6k citations indexed

About

Behnam Badie is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Behnam Badie has authored 137 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 38 papers in Genetics and 36 papers in Immunology. Recurrent topics in Behnam Badie's work include Glioma Diagnosis and Treatment (38 papers), CAR-T cell therapy research (34 papers) and Immune cells in cancer (23 papers). Behnam Badie is often cited by papers focused on Glioma Diagnosis and Treatment (38 papers), CAR-T cell therapy research (34 papers) and Immune cells in cancer (23 papers). Behnam Badie collaborates with scholars based in United States, China and Brazil. Behnam Badie's co-authors include Jill Schartner, Christine E. Brown, Leying Zhang, Jana Portnow, Stephen J. Forman, Massimo D’Apuzzo, Renate Starr, Anna Carolina Carvalho da Fonseca, Darya Alizadeh and Jyoti J. Watters and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Behnam Badie

135 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

2015 592 citations Christine E. Brown, Behnam Badie et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Behnam Badie United States	49	2.7k	2.4k	2.0k	1.8k	1.4k	137	7.6k
Jeffrey N. Bruce United States	61	2.3k 0.9×	1.9k 0.8×	4.6k 2.3×	3.8k 2.2×	1.1k 0.8×	316	12.6k
Peter E. Fecci United States	38	2.4k 0.9×	2.2k 0.9×	2.1k 1.0×	1.1k 0.6×	689 0.5×	150	5.2k
Dolores Hambardzumyan United States	43	2.8k 1.0×	2.8k 1.2×	3.5k 1.8×	4.4k 2.5×	669 0.5×	94	9.5k
Toshihiko Wakabayashi Japan	49	1.2k 0.5×	1.0k 0.4×	1.9k 1.0×	2.4k 1.4×	1.2k 0.9×	388	8.3k
Viviane Tabar United States	45	2.1k 0.8×	1.1k 0.4×	3.1k 1.5×	7.9k 4.5×	1.2k 0.9×	153	13.1k
Hirofumi Hamada Japan	53	2.7k 1.0×	2.0k 0.8×	2.8k 1.4×	5.7k 3.3×	373 0.3×	227	11.7k
Derek A. Wainwright United States	36	2.0k 0.7×	2.4k 1.0×	1.2k 0.6×	1.6k 0.9×	526 0.4×	105	5.5k
Simone P. Niclou Luxembourg	50	1.3k 0.5×	874 0.4×	1.7k 0.9×	3.2k 1.8×	598 0.4×	113	6.7k
Patrick Roth Switzerland	44	1.9k 0.7×	1.5k 0.6×	3.2k 1.6×	2.0k 1.1×	538 0.4×	202	7.2k
Edward W. Scott United States	43	1.5k 0.6×	1.9k 0.8×	1.7k 0.9×	4.2k 2.4×	392 0.3×	110	8.4k

Countries citing papers authored by Behnam Badie

Since Specialization

Citations

This map shows the geographic impact of Behnam Badie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behnam Badie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behnam Badie more than expected).

Fields of papers citing papers by Behnam Badie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behnam Badie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behnam Badie. The network helps show where Behnam Badie may publish in the future.

Co-authorship network of co-authors of Behnam Badie

This figure shows the co-authorship network connecting the top 25 collaborators of Behnam Badie. A scholar is included among the top collaborators of Behnam Badie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behnam Badie. Behnam Badie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vélez-Cordero, J. Rodrigo, et al.. (2024). Towards a Robotically Steerable Laser Ablation Probe. PubMed. 2024. 1–7. 1 indexed citations

Barish, Michael E., Lihong Weng, Yubo Zhai, et al.. (2022). Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma. Neoplasia. 30. 100801–100801. 11 indexed citations

Alizadeh, Darya, Robyn A. Wong, Sharareh Gholamin, et al.. (2021). IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discovery. 11(9). 2248–2265. 103 indexed citations

Badie, Behnam, Michael E. Barish, Ammar Chaudhry, et al.. (2021). A phase 1 study to evaluate chimeric antigen receptor (CAR) T cells incorporating a chlorotoxin tumor-targeting domain for patients with MMP2+ Recurrent or progressive glioblastoma (NCT04214392).. Journal of Clinical Oncology. 39(15_suppl). TPS2662–TPS2662. 9 indexed citations

Zhou, Hui, Huili Liu, Leying Zhang, et al.. (2020). Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice. Clinical Cancer Research. 26(11). 2740–2753. 11 indexed citations

Wang, Dongrui, Briana C. Prager, Ryan C. Gimple, et al.. (2020). CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies. Cancer Discovery. 11(5). 1192–1211. 121 indexed citations

Portnow, Jana, Behnam Badie, M. Suzette Blanchard, et al.. (2020). Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients. Cancer Gene Therapy. 28(3-4). 294–306. 15 indexed citations

Cao, Pengpeng, et al.. (2020). Dynamically Programmable Magnetic Fields for Controlled Movement of Cells Loaded with Iron Oxide Nanoparticles. ACS Applied Bio Materials. 3(7). 4139–4147. 7 indexed citations

Alizadeh, Darya, et al.. (2018). Immunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells. Bioconjugate Chemistry. 29(5). 1659–1668. 25 indexed citations

10.

Sahoo, Prativa, Paul Frankel, Julie A. Ressler, et al.. (2018). Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival. Stem Cells International. 2018. 1–9. 5 indexed citations

11.

Portnow, Jana, Timothy W. Synold, Behnam Badie, et al.. (2016). Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients. Clinical Cancer Research. 23(12). 2951–2960. 127 indexed citations

12.

Brown, Christine E., Behnam Badie, Michael E. Barish, et al.. (2015). Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma. Clinical Cancer Research. 21(18). 4062–4072. 592 indexed citations breakdown →

13.

Herrmann, Andreas, Gregory Cherryholmes, Anne Schroeder, et al.. (2014). TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting. Cancer Research. 74(18). 5218–5228. 60 indexed citations

14.

Chen, Xuebo, Leying Zhang, Junling Liang, et al.. (2014). RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma. Cancer Research. 74(24). 7285–7297. 132 indexed citations

15.

Wang, Huaqing, Leying Zhang, Xuebo Chen, et al.. (2013). S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages. Clinical Cancer Research. 19(14). 3764–3775. 78 indexed citations

16.

Fan, Haitao, Ian Zhang, Xuebo Chen, et al.. (2012). Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice. Clinical Cancer Research. 18(20). 5628–5638. 48 indexed citations

17.

Alizadeh, Darya, et al.. (2010). Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy. Clinical Cancer Research. 16(13). 3399–3408. 64 indexed citations

18.

Zhao, Dongchang, Darya Alizadeh, Leying Zhang, et al.. (2010). Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity. Clinical Cancer Research. 17(4). 771–782. 133 indexed citations

19.

Brown, Christine E., Renate Starr, Catalina Martínez, et al.. (2009). Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells. Cancer Research. 69(23). 8886–8893. 113 indexed citations

20.

Badie, Behnam & Jill Schartner. (2000). Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental Gliomas. Neurosurgery. 46(4). 957–962. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact